Migraine - symptomatology, diagnostics, non-pharmacological and pharmacological procedures

Surprisingly, migraine is in the 3rd place of all diseases occurring in the world and affects 12% of the population, between the ages of 25 and 55. Migraine headaches significantly affect the quality of human life, while limiting proper bio-psycho-social functioning. This explains the vigorous efforts of researchers to establish the still enigmatic pathomechanism of the disease. The dichotomy of migraine is based on its division into with aura or without aura, and its semiology is extremely diverse. Pharmacological and non-pharmacological treatment of migraines should include 2 strategies: immediate, aimed at combating the seizure, and prophylactic, the goal of which is to reduce the onset of the disease